about
Neuroimaging biomarkers of neurodegenerative diseases and dementiaAlteration of Basal Ganglia and Right Frontoparietal Network in Early Drug-Naïve Parkinson's Disease during Heat Pain Stimuli and Resting StateNeuroimaging of Parkinson's disease: Expanding views.Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniquesBrain imaging and networks in restless legs syndrome.Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats.Aberrant Intra- and Internetwork Functional Connectivity in Depressed Parkinson's DiseaseFunctional connectivity in the basal ganglia network differentiates PD patients from controlsPET/SPECT imaging agents for neurodegenerative diseases.Practical management of heterogeneous neuroimaging metadata by global neuroimaging data repositoriesPutamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases.Alteration of Brain Functional Networks in Early-Stage Parkinson's Disease: A Resting-State fMRI Study.Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.Association of specific frequency bands of functional MRI signal oscillations with motor symptoms and depression in Parkinson's diseaseLow Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort.Resting state functional connectivity of the striatum in Parkinson's disease.Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrityUse of functional imaging across clinical phases in CNS drug development.Neuromelanin Imaging and Dopaminergic Loss in Parkinson's DiseaseA platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.Biomarkers of Parkinson's disease: current status and future perspectives.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.Computer-based magnetic resonance imaging as a tool in clinical diagnosis in neurodegenerative diseases.Oral biomarkers in exercise-induced neuroplasticity in Parkinson's disease.Imaging Systemic Dysfunction in Parkinson's Disease.Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease.Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns.Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.Are prescribed benzodiazepines likely to affect the availability of the 18 kDa translocator protein (TSPO) in PET studies?Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.Decreased serum proNGF concentration in patients with Parkinson's disease.Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.International validation of a behavioral scale in Parkinson's disease without dementia.
P2860
Q27691820-BF13B332-B48D-423A-81D4-B1182D6ABF6DQ28386521-F73DB936-1505-4CE0-9E73-B182A7E5D5A7Q28387732-FF83EA44-C2F2-4211-A547-329AA21EF4BDQ28395854-E18FE2B1-09E1-45D4-BA4E-62295711CDADQ31142064-348833A7-26F9-4A5F-A1F4-B119A51E989EQ33625060-0BAD94A9-A240-4337-92AF-1F521FCC6BC1Q33747070-4F6E7130-9004-4CB4-8843-11FB8636AA81Q33981257-1DE0DA3D-2570-4167-9903-69400623B90CQ34156602-0E297B90-CD13-448F-80D4-88B7BE7E00A9Q34217253-4ED52FFF-C1E4-4A26-9740-BEE88F9F491EQ35794074-9DAB953C-FBD8-4B58-8035-CF7B7C2BFA3CQ35827114-75060E63-E1C4-42A1-B2BC-44052E28D95BQ36271585-E4EEFE24-DA01-423B-9B60-8A1B2AB44956Q36287617-80D956BE-74FF-4989-BB18-2DDB3F4E2470Q36314846-05FC93DD-1909-4780-B88F-3161F19C91DCQ36320018-F1AEA101-F619-4542-847D-65114A1D718BQ36474693-12FC9FA8-4F17-4067-95C7-96A8802D85A7Q36508977-6B55B434-9434-4BFD-AD8B-23E6AABA9A8EQ37065259-DFA7FE78-F3DD-4E52-A4C4-357A8897EC1CQ37192855-3F5AD05A-FF81-4E7D-B739-430B44BD15C5Q37600861-D9BF5099-0972-4A2A-8686-17A89389CFE5Q37696024-9C4A6157-3E2F-4D48-B8FA-7A3F83B72E3AQ38043841-D1CF62CE-B164-426B-8EBC-CD2EFA6B2B6CQ38650395-CE361767-18C2-49C9-93AA-DEADDC8DFA46Q38658393-770C1D88-0FCB-4300-AE6B-0B386B4BE00EQ38699508-E09BF9C0-BE5E-48AE-AE65-75F5E699564FQ38710593-93B24886-0957-419A-9B3E-DC47CCDD5A79Q38733922-001F7CE1-BEF6-4BED-BD0F-6AC310EDFB56Q38807024-4BEE726F-427F-4E34-B69C-6F0019A5A219Q41143664-69FDF716-B839-479B-A828-527F554EFEDEQ41492379-B2940863-3150-4441-9B75-3C709826C93DQ41778722-F677ACAA-3C47-4005-A866-99EC7EF41759Q42369736-960A024C-68FC-4605-AD09-844BCFCFAF16Q45787444-FF0C1D76-2BAE-4FC3-8714-4CE9A53A2194Q47336383-E38FDEE2-6665-44C9-8D7D-E185FF43245EQ47338262-44C30176-A4CD-49AD-A026-6230C038BAC3Q47694020-A4C8C8CC-CE8B-4DF9-9196-55E2C89813B3Q47755927-59080274-EA63-4BAA-8B0E-FEA61DA52EEBQ47998172-6E04A18B-18E9-413F-A007-076217D1E9C7Q48088853-0253A749-494F-4BB7-8F65-FADAEE864E4A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Imaging biomarkers in Parkinson's disease.
@ast
Imaging biomarkers in Parkinson's disease.
@en
Imaging biomarkers in Parkinson's disease.
@nl
type
label
Imaging biomarkers in Parkinson's disease.
@ast
Imaging biomarkers in Parkinson's disease.
@en
Imaging biomarkers in Parkinson's disease.
@nl
prefLabel
Imaging biomarkers in Parkinson's disease.
@ast
Imaging biomarkers in Parkinson's disease.
@en
Imaging biomarkers in Parkinson's disease.
@nl
P1476
Imaging biomarkers in Parkinson's disease
@en
P2093
David J Brooks
Nicola Pavese
P304
P356
10.1016/J.PNEUROBIO.2011.08.009
P577
2011-08-30T00:00:00Z